Tarragon
artemisia dracunculus
Medicinal Actions
Analysis pending research update.
Primary Conditions Treated
Anorexia
Arthrosis
Atherosclerosis
Bacteria
Biliousness
Bite
Bruise
Cancer
sinew
Capillary Fragility
Cold
Cramp
Diabetes
Diarrhea
Dysmenorrhea
Edema
Fever
Fungus
Gas
Headache
Heart
High Blood Pressure
Infection
Inflammation
Insomnia
Mycosis
Pain
Parturition
Rheumatism
Sting
Stroke
Swelling
Toothache
Tumor
Water Retention
Worm
Wound
General Dosage
1–2 tsp leaf/cup to 3 ×/day. 1–2 tsp leaf/cup to 3 ×/day.
Safety & Contraindications
Class 1. 81% of EO may be estragole. Contains one compound that is carcinogenic in mice. Pregnant women might avoid.“Hazards and/or side effects not known for proper therapeutic dosages”. LD50 = 215 mg/kg ipr mus. Class 1. 81% of EO may be estragole. Contains one compound that is carcinogenic in mice. Pregnant women might avoid.“Hazards and/or side effects not known for proper therapeutic dosages”. LD50 = 215 mg/kg ipr mus.
!